QIM
NEO icon

Quantitative Investment Management’s NeoGenomics NEO Stock Holding History

Quantitative Investment Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,408
Closed -$598K – 389
2021
Q3 		$598K Buy
+12,408
New +$574K 0.05% 257
2020
Q4 		– Sell
-9,653
Closed -$356K – 556
2020
Q3 		$356K Buy
+9,653
New +$359K 0.03% 300

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantitative Investment Management's NEO Position: Q4 2021 in Review

Quantitative Investment Management sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 12,408 shares — an estimated $598K sold.

Quantitative Investment Management first reported a position in NEO in Q3 2020 and held it in 2 quarters. The position peaked at $598K in Q3 2021. 307 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

  • Quantitative Investment Management reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
  • Quantitative Investment Management sold 12,408 NeoGenomics shares in Q4 2021, an estimated $598K.
  • Quantitative Investment Management first reported a position in NeoGenomics in Q3 2020 and held it in 2 quarters.
  • Quantitative Investment Management's NeoGenomics position peaked at $598K in Q3 2021.
  • 307 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on Quantitative Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.